Study of Etanercept and Celecoxib to Treat Temporomandibular Disorders (Painful Joint Conditions)

NCT00001955 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

150

Enrollment

NIH

Sponsor class

Conditions

Temporomandibular Joint Disorder

Interventions

DRUG: Etanercept
DRUG: Celecoxib

Sponsor

National Institute of Dental and Craniofacial Research (NIDCR)